期刊文献+

蝎子PCR法与传统测序法检测K-ras基因突变的比较

Comparison of the scorpion PCR and the Sanger sequencing method in K-ras gene mutation detection
下载PDF
导出
摘要 目的建立一种简单、便捷、有效检测K-ras突变的蝎子PCR新方法。方法同时用蝎子PCR法和Sanger测序法对87例结直肠癌组织的K-ras基因进行热突变型G12D(GGT>GAT)进行检测,统计其符合率。结果 87例结直肠癌组织样本中,蝎子PCR法和Sanger测序法检测到同样9例G12D突变,其符合率为100%。结论蝎子PCR法能有效检测到K-ras突变,且比Sanger测序法更为简便、快速,适合临床应用。 Objective To establish a simple, convenient and effective scorpion PCR method to detect K-ras gene mutation. Methods K-ras gene mutation G12D(GGTGAT) of 87 colorectal cancer tissue samples were tested by scorpion PCR method and Sanger sequencing method. And coincidence rate was calculated. Results 9 cases G12D mutations were detected in 87 colorectal cancer tissue samples by both scorpion PCR method and sanger sequencing method. The coincidence rate was 100%. Conclusion The scorpion PCR method can detect K-ras gene mutation effectively. And it's more convenient and faster than Sanger sequencing method. It's very suitable for the clinical application in K-ras gene mutation detection.
出处 《分子诊断与治疗杂志》 2012年第6期393-396,共4页 Journal of Molecular Diagnostics and Therapy
关键词 K-RAS 蝎子PCR法 Sanger测序法 K-ras Scorpion PCR method Sanger sequencing method
  • 相关文献

参考文献13

  • 1Amado R G, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer[J]. J Clin Oncol, 2008, 26(10): 1626-1634.
  • 2Ma E S, Wong C L, Law F B, et al. Detection of KRASmutations in colorectal cancer by high-resolution melting analysis[J]. J Clin Pathol, 2009, 62(10): 886-891.
  • 3Bokemeyer C, Bondarenko I, Hartmann J T, et al. KRAS status and efficacy of first-line treatment of patients with metastatic colorectal cancer(mCRC) with FOLFOX with or without cetuximab: The OPUS experience[J]. J Clin Oncol, 2008, 26(15s): 4000.
  • 4Soulires D, Greer W, Magliocco A M, et al. KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies[J]. Curr Oncol, 2010, 17(suppll): $31-40.
  • 5Karapetis C S, Khambata-Ford S, Jonker D J, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer[J]. N Engl J Med, 2008, 359(17): 1757-1765.
  • 6Brink M, de Goeij A F, Weijenberg M P, et al. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study[J]. Carcinogenesis, 2003, 24(4): 703-710.
  • 7Bos J L. Ras oncogenes in human cancer: a review[J]. Cancer Res, 1989, 49 (17): 4682-4689.
  • 8Adjei A A. Blocking oncogenic Ras signaling for cancertherapy[J]. J Natl Cancer Inst, 2001, 93 (14): 1062-1074.
  • 9袁平,孙孟红,张锦生,朱雄增.中国人大肠癌K-ras基因突变的研究[J].临床与实验病理学杂志,2000,16(6):464-466. 被引量:20
  • 10Holdhoff M, Schmidt K, Donehower R, et al. Analysis of circulating tumor DNA to confirm somatic KRAS mutations[J]. J Natl Cancer Inst, 2009, 101(18): 1284-1285.

二级参考文献3

  • 1Tang W Y,Br J Cancer,1999年,81卷,237页
  • 2Ko J M,Cancer Lett,1998年,134卷,169页
  • 3Chiang J W,Cancer Res,1998年,58卷,3289页

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部